Vor Biopharma Inc. (VOR)
Trading
Quantity
Profitability
Ownership
Largest Insider Buys in Sector
VOR Insider Trading Activity
VOR Median Price and Trade Amounts History Chart
Statistics of Insider Transactions
Amount of Insider Buys and Sells
Buys | $38,750,000 | 1 | 20 |
Sells | $39,935 | 4 | 80 |
Related Transactions
| Reprogrammed Interchange LLC | 10 percent owner | 1 | $38.75M | 0 | $0 | $38.75M |
| Attar Eyal C. | CHIEF MEDICAL OFFICER | 0 | $0 | 4 | $39,935 | $-39,935 |
About Vor Biopharma Inc.
Vor Biopharma, Inc., a clinical-stage company, develops engineered hematopoietic stem cell (eHSC) therapies for cancer patients. It is developing VOR33, an eHSC product candidate that is in phase 1/2 to treat acute myeloid leukemia (AML) and other hematological malignancies. The company's VOR33 eHSCs lacks CD33, a protein that is expressed by AML blood cancer cells. The company's eHSCs targeted therapies, such as CAR-Ts, bispecific antibodies, and antibody-drug conjugates provide treatment for blood cancers. Vor Biopharma, Inc. has a …
Insider Activity of Vor Biopharma Inc.
Over the last 12 months, insiders at Vor Biopharma Inc. have bought $38.75M and sold $39,935 worth of Vor Biopharma Inc. stock.
On average, over the past 5 years, insiders at Vor Biopharma Inc. have bought $56.19M and sold $5.08M worth of stock each year.
Highest buying activity among insiders over the last 12 months: Reprogrammed Interchange LLC (10 percent owner) — $38.75M.
The last purchase of 38,974,101 shares for transaction amount of $38.75M was made by Reprogrammed Interchange LLC (10 percent owner) on 2024‑12‑30.
List of Insider Buy and Sell Transactions, Vor Biopharma Inc.
| 2025-02-13 | Sale | Attar Eyal C. | CHIEF MEDICAL OFFICER | 2,227 0.0018% | $1.42 | $3,162 | -32.50% | |
| 2025-02-10 | Sale | Attar Eyal C. | CHIEF MEDICAL OFFICER | 2,554 0.0036% | $1.37 | $3,499 | -34.78% | |
| 2024-12-30 | Reprogrammed Interchange LLC | 10 percent owner | 38.97M 44.4324% | $0.99 | $38.75M | +11.76% | ||
| 2024-12-27 | Sale | Attar Eyal C. | CHIEF MEDICAL OFFICER | 10,334 0.0158% | $1.25 | $12,918 | +4.72% | |
| 2024-06-03 | Sale | Attar Eyal C. | CHIEF MEDICAL OFFICER | 14,645 0.0209% | $1.39 | $20,357 | -35.05% | |
| 2021-11-16 | Sale | PARMAR KUSH | 330,706 0.7914% | $15.30 | $5.06M | -69.06% | ||
| 2021-11-16 | Sale | 5AM Ventures VI, L.P. | 10 percent owner | 330,706 0.7914% | $15.30 | $5.06M | -69.06% | |
| 2021-02-09 | RA CAPITAL MANAGEMENT, L.P. | 2.98M 5.6047% | $18.00 | $53.63M | -63.24% | |||
| 2021-02-09 | PARMAR KUSH | 555,555 1.045% | $18.00 | $10M | -63.24% | |||
| 2021-02-09 | 5AM Ventures VI, L.P. | 10 percent owner | 555,555 1.045% | $18.00 | $10M | -63.24% |
Insider Historical Profitability
| Reprogrammed Interchange LLC | 10 percent owner | 38974101 31.2162% | $29.34M | 1 | 0 | |
| RA CAPITAL MANAGEMENT, L.P. | 8297265 6.6457% | $6.25M | 1 | 0 | <0.0001% | |
| PARMAR KUSH | 1766634 1.415% | $1.33M | 1 | 1 | <0.0001% | |
| 5AM Ventures VI, L.P. | 10 percent owner | 1766634 1.415% | $1.33M | 1 | 1 | <0.0001% |
Historical Insider Profitability vs. Competitors
$12,784,645 | 193 | 20.49% | $86.49M | |
$4,919,189 | 138 | 5.22% | $95.62M | |
$22,597,521 | 91 | 4.59% | $94.71M | |
$16,245,616 | 40 | 123.58% | $96.01M | |
$7,147,964 | 34 | 24.78% | $89.09M |
VOR Institutional Investors: Active Positions
| Increased Positions | 21 | +26.58% | 19M | +41.69% |
| Decreased Positions | 31 | -39.24% | 4M | -8.63% |
| New Positions | 14 | New | 2M | New |
| Sold Out Positions | 16 | Sold Out | 3M | Sold Out |
| Total Postitions | 69 | -12.66% | 62M | +33.05% |
VOR Ownership Change vs Market
Institutional Investor Ownership
| Ra Capital Management, L.P. | $34,492.00 | 31.72% | 39.65M | +17M | +74.28% | 2024-12-31 |
| Fmr Llc | $5,585.00 | 5.14% | 6.42M | -651,477 | -9.21% | 2024-12-31 |
| 5Am Venture Management, Llc | $5,535.00 | 5.09% | 6.36M | 0 | 0% | 2024-12-31 |
| Vanguard Group Inc | $1,690.00 | 1.55% | 1.94M | -11,464 | -0.59% | 2024-12-31 |
| Cowen And Company, Llc | $1,062.00 | 0.98% | 1.22M | +1M | New | 2024-09-30 |
| Johnson & Johnson | $935.00 | 0.86% | 1.07M | 0 | 0% | 2024-12-31 |
| Lynx1 Capital Management Lp | $554.00 | 0.51% | 637,218 | +637,218 | New | 2024-12-31 |
| Sarissa Capital Management Lp | $538.00 | 0.49% | 618,000 | 0 | 0% | 2024-12-31 |
| Renaissance Technologies Llc | $461.00 | 0.42% | 529,500 | -226,511 | -29.96% | 2024-12-31 |
| Blackrock, Inc. | $425.00 | 0.39% | 488,363 | +709 | +0.14% | 2024-12-31 |